Anna Khomenko

Anna Khomenko

Auto-generated profile, based on publicly available information

Anna Khomenko

Palladin Institute of Biochemistry, Department of Biochemistry of Vitamins and Coenzymes, Kyiv, Ukraine

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Biochemistry and Cell Biology
Verified
Journal Article
Closed access
OLOlha Lisakovska
Olha Lisakovska
ISIhor Shymanskyy
Ihor Shymanskyy
AMAnna Mazanova
Anna Mazanova
AKAnna Khomenko
Anna Khomenko
MVMykola Veliky
Mykola Veliky
The study was carried out to define whether prednisolone-induced damage to hepatic cells is accompanied by excessive nitric oxide (NO) levels associated with nuclear factor kappa B (NF-κB)/inducible NO synthase (iNOS) activation and evaluate the efficacy of the treatment with vitamin D3. Histopathological examination, activities of liver transaminases (alanine aminotransferase and aspartate aminotransferase), and cell death assays consistently showed that prednisolone (5 mg/kg body weight, 30 days) induces chronic liver injury in female Wistar rats. Specifically, increased hepatocellular necrosis and caspase-3-dependent apoptosis were observed. Prednisolone enhanced iNOS protein expression, NO generation, and tyrosine nitration in liver cells. Despite unchanged hepatic level of the NF-κB/p65 protein, prednisolone increased inhibitory κB-α (IκB-α) degradation, nuclear translocation, and phosphorylation of NF-κB/p65 at Ser311, indicating that NF-κB activation can be involved in the induction of iNOS/NO. All changes were associated with a 2.9-fold decrease in the serum content of 25-hydroxyvitamin D3 and significant reduction of hepatic vitamin D3 receptor (VDR) expression that points reliably to vitamin D3 deficiency and failures in VDR signaling. Vitamin D3 co-administration (100 IU/rat, 30 days) prevented glucocorticoid-evoked abnormalities in hepatic tissue. In conclusion, prednisolone-induced liver disturbances were associated with the impairment of NF-κB/iNOS/NO responses that can be ameliorated by vitamin D3 treatment through VDR-mediated mechanisms.

31 October 2016 in The Ukrainian Biochemical Journal
Verified
Journal Article
Open access
ISI. O. Shymanskyy
I. O. Shymanskyy
OLOlha Lisakovska
Olha Lisakovska
AMAnna Mazanova
Anna Mazanova
DLD. O. Labudzynskyi
D. O. Labudzynskyi
AKA. V. Khomenko
A. V. Khomenko
MVMykola Veliky
Mykola Veliky
The study was designed to evaluate reactive oxygen species (ROS)/nitric oxide (NO) formation and apoptotic/necrotic cell death elicited by prednisolone in peripheral blood and bone marrow mononuclear cells and to define the efficacy of vitamin D3 to counter glucocorticoid (GC)-induced changes. It was shown that prednisolone (5 mg per kg of female Wistar rat’s body weight for 30 days) evoked ROS and NO overproduction by blood mononuclear cells (monocytes and lymphocytes) that correlated with increased cell apoptosis and necrosis. In contrast, prednisolone did not affect ROS/NO levels in bone marrow mononuclear cells that corresponded to lower level of cell death than in the control. Alterations of prooxidant processes revealed in mononuclear cells and associated with GC action were accompanied by vitamin D3 deficiency in animals, which was assessed by the decreased level of blood serum 25-hydroxivitamin D3 (25OHD3). Vitamin D3 administration (100 IU per rat daily for 30 days, concurrently with prednisolone administration) completely restored 25OHD3 content to the control values and significantly reversed ROS and NO formation in blood mononuclear cells, thus leading to decreased apoptosis. In bone marrow, vitamin D3 activated ROS/NO production and protein nitration that may play a role in prevention of prednisolone-elicited increase in bone resorption. We conclude that vitamin D3 shows a profound protection against GC-associated cellular damage through regulating intracellular ROS/NO formation and cell death pathways.

27 June 2013 in The Ukrainian Biochemical Journal
Verified
Journal Article
Open access
AKA. V. A. V. Khomenko
A. V. A. V. Khomenko
Glucocorticoid therapy is accompanied by development of processes typical of steroid osteoporosis. Indirect effects of glucocorticoids on the bone tissue are due to changes in mineral metabolism, which is regulated by vitamin D3. In this connection, we studied the influence of prednisolone on cholecalciferol metabolism. The study has shown that prednisolone action causes impairment of cholecalciferol metabolism in hepatocytes due to inhibiting vitamin D3 25-hydroxylase activity. Microsomal (CYP2R1) and mitochondrial (CYP27A1) isoenzymes of vitamin D3 25-hydroxylase were found to function at different concentrations of the substrate. The relative protein contents of the isoenzymes greatly differed in the liver with the prevalence of CYP27A1 over CYP2R1. Prednisolone administration resulted in the lowering of both mitochondrial and microsomal isoenzymes of vitamin D3 25-hydroxylase. The inhibition of vitamin D3 25-hydroxylating system in hepatocytes contributed to a significant reduction in blood serum 25OHD3.


27 August 2022
Verified
Reference Entry
Open access
AKAnna Khomenko
Anna Khomenko
Single live pregnancy estimated at 11 weeks 0 days gestation. Sonographic findings raise suspicion for Mullerian duct anomaly of the uterus. IUD may be within the left uterine horn and the live pregnancy may be within the right uterine horn, ho...

26 September 2026 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
ISIhor Shymanskyi
Ihor Shymanskyi
OLOlha Lisakovska
Olha Lisakovska
AKAnna Khomenko
Anna Khomenko
VBVasyl Bilous
Vasyl Bilous
MVMykola Veliky
Mykola Veliky